ANDLAUER HEALTHCARE GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.5 CAD | +1.08% |
|
-2.34% | -8.49% |
| Sales 2024 * | 670M 491M | Sales 2025 * | 710M 520M | Capitalization | 1.55B 1.14B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.37 x |
| Net Debt 2024 * | 35.5M 26.03M | Net cash position 2025 * | 58M 42.53M | EV / Sales 2025 * | 2.11 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 2,290 |
| Yield 2024 * |
1.05% | Yield 2025 * |
1.33% | Free-Float | 46.48% |
More Fundamentals
* Assessed data
More news
Latest transcript on Andlauer Healthcare Group Inc.
More recommendations
More press releases
| 1 day | +1.08% | ||
| 1 week | -2.34% | ||
| 1 month | -10.09% | ||
| 3 months | -6.95% | ||
| 6 months | -6.25% | ||
| Current year | -8.49% |
1 week
36.43
38.69
1 month
36.4342.54
Current year
36.4344.12
1 year
36.4346.47
3 years
35.2655.97
5 years
18.0055.97
10 years
18.0055.97
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Andlauer
CEO | Chief Executive Officer | 59 | 19-11-11 |
Peter Bromley
DFI | Director of Finance/CFO | 60 | 18-12-31 |
Graham Cromb
PRN | Corporate Officer/Principal | - | 23-05-03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Andlauer
CEO | Chief Executive Officer | 59 | 19-11-11 |
| Director/Board Member | 51 | 19-11-11 | |
Thomas Wellner
BRD | Director/Board Member | 59 | 19-11-11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.45% | 11 M€ | -.--% | ||
| 0.06% | 1 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 37.5 | +1.08% | 192,886 |
| 24-05-30 | 37.1 | -0.56% | 36,696 |
| 24-05-29 | 37.31 | -0.53% | 46,870 |
| 24-05-28 | 37.51 | -1.65% | 11,305 |
| 24-05-27 | 38.14 | -0.68% | 6,683 |
Delayed Quote Toronto S.E., May 31, 2024 at 04:00 pm EDT
More quotes
Andlauer Healthcare Group Inc. is a Canada-based supply chain management company. It offers robust platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. Its segments include Specialized Transportation and Healthcare Logistics. The Specialized Transportation segment offers temperature-controlled, as well as non-temperature controlled, ground transportation, air freight forwarding and last mile transportation services to its clients under its ATS Healthcare, ATS Dedicated, Boyle Transportation and Skelton Truck Lines brands. The Healthcare Logistics segment offers logistics and distribution services and packaging solutions to its clients under its Accuristix and LSU brands. It offers services to healthcare manufacturers, wholesalers, distributors and 3PL providers, through its technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products and others.
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
37.5
CAD
Average target price
49.43
CAD
Spread / Average Target
+31.81%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.49% | 1.14B | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| -5.56% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +70.11% | 13.09B | |
| +79.20% | 13.21B | |
| +40.44% | 12.9B |
- Stock Market
- Equities
- AND Stock
